Results 1 to 10 of about 70 (69)

MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH

Cell Metabolism, 2022
Wei Ying, Jerrold M. Olefsky, Zhongmou Jin   +2 more
exaly  

The miR-34 family in cancer and apoptosis

Cell Death and Differentiation, 2009
H Hermeking
exaly  

Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma

Journal of Hematology and Oncology, 2015
Yanning Liu, Zhi Chen, Shanshan Wu
exaly  

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of Oncology, 2013
Glen Reid, Michaela B. Kirschner, Casey M Wright   +2 more
exaly  

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

British Journal of Cancer, 2011
Nijiro Nohata, H Enokida
exaly  

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

Oncogene, 2012
Biswajyoti Sahu, Tapio Visakorpi, Alfonso Urbanucci   +2 more
exaly  

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

British Journal of Cancer, 2010
H Enokida
exaly  

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

International Journal of Cancer, 2011
Susan Clark, Lars Dyrskjøt, Michael Borre   +2 more
exaly  

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis

Journal of Cancer Research and Clinical Oncology, 2010
Lingxiang Liu, Hua Shen
exaly  

Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis

Cell Reports, 2017
David A. Ford, Noemi Rotllan, Manuel Mayr   +2 more
exaly